(Diethylamino)sulfur trifluoride → HCID 86621267, compound
Reaction equation
[F:1][C:2]1[C:3]([NH:27][C:28]2[CH:33]=[CH:32][C:31]([I:34])=[CH:30][C:29]=2[F:35])=[C:4]([C:9]([N:11]2[CH2:14][C:13]([CH2:16][N:17]([CH2:25][CH3:26])[C:18](=[O:24])[O:19][C:20]([CH3:23])([CH3:22])[CH3:21])(O)[CH2:12]2)=[O:10])[CH:5]=[CH:6][C:7]=1[F:8].CCN(S(F)(F)[F:42])CC>C(Cl)(Cl)Cl>[F:1][C:2]1[C:3]([NH:27][C:28]2[CH:33]=[CH:32][C:31]([I:34])=[CH:30][C:29]=2[F:35])=[C:4]([C:9]([N:11]2[CH2:12][C:13]([CH2:16][N:17]([CH2:25][CH3:26])[C:18](=[O:24])[O:19][C:20]([CH3:23])([CH3:21])[CH3:22])([F:42])[CH2:14]2)=[O:10])[CH:5]=[CH:6][C:7]=1[F:8]Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To 1,1-dimethylethyl [{1-({3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}carbonyl)-3-hydroxyazetidin-3-yl]methyl}ethylcarbamate (27 mg, 0.044 mmol), prepared using procedures similar to those in Example 3 and followed by Boc-protection, in chloroform (2.5 mL) added DAST (11.8 μL, 0.089 mmol) and stirred for 3.5 hr at room temperature. Quenched with water (15 mL), partitioned phases and extracted aqueous phase with chloroform (2×15 mL). The combined chloroform extracts were dried over sodium sulfate, filtered and the filtrate concentrated in vacuo. The residue was purified on a silica gel column to afford 1,1-dimethylethyl [{1-({3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}carbonyl)-3-fluoroazetidin-3-yl]methyl}ethylcarbamate (19.0 mg, 70%).
Workup
- customQuenched with water (15 mL)
- custompartitioned phases
- extractionextracted aqueous phase with chloroform (2×15 mL)
- dry with materialThe combined chloroform extracts were dried over sodium sulfate
- filtrationfiltered
- concentrationthe filtrate concentrated in vacuo
- customThe residue was purified on a silica gel column
Sources & evidence
- ORD record
- ord-ee57a6a553b84c479a0f109e58af38f9
- Source dataset
- uspto-grants-2011_08
- Patent number
- US07999006B2
Reaction notes
Loading…